title: Validated spectrophotometric methods for the simultaneous determination of ciprofloxacin hydrochloride and metronidazole in tablets.
abstract: A binary mixture of ciprofloxacin hydrochloride (CIP) and metronidazole (MET) was determined by five simple and accurate methods, without prior separation. In the first method, CIP was determined by second derivative spectrophotometric method ((2)D) by measuring the amplitude at 282 nm (zero ordinate value of MET). On the other hand, the determination of MET was based on isosbestic point technique, where the total content of the mixture was determined at 294.5 nm (isosbestic point), then the content of MET could be calculated by subtraction. The second method was first derivative ratio spectrophotometric method ((1)DD) where the total amplitude at 261 and 285 nm and the amplitude at 295.5 nm were selected to simultaneously determine CIP and MET in binary mixture, respectively. The third method was based on dual wavelength analysis, in which two wavelengths were selected, at which the absorbances of the other component were the same. The fourth method depends on using Q-analysis method (absorbance ratio) which involves the formation of Q-absorbance equation using the respective absorptivity values at 294.5 nm (isosbestic point) and 281.5 nm (λ(max) of CIP). The fifth method is partial least-squares (PLS) chemometric technique for determination of CIP and MET. The developed methods were successfully applied to the analysis of CIP and MET in laboratory prepared mixtures and tablets with good recoveries and their validation was carried out following the International Conference on Harmonization (ICH) guidelines. The results obtained were statistically compared with each other showing no significant difference with respect to accuracy and precision.
authors: Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt. mariannealphonse22@yahoo.com
authors: Marianne Alphonse
authors: MA
authors: Mahrouse
authors: Ehab Farouk
authors: EF
authors: Elkady
mesh_terms: D000890:Anti-Infective Agents / Q000032:analysis*; D002939:Ciprofloxacin / Q000032:analysis*; D004338:Drug Combinations; D008795:Metronidazole / Q000032:analysis*; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012680:Sensitivity and Specificity; D013053:Spectrophotometry / Q000379:methods*; D013607:Tablets
chemical_list: D000890:Anti-Infective Agents; D004338:Drug Combinations; D004364:Pharmaceutical Preparations; D013607:Tablets; D008795:Metronidazole; D002939:Ciprofloxacin